To The Moon

Sign Up

ARKG Investment Tracker

Source from：official website ARKG is an exchange-traded fund (ETF) managed by Cathie Wood, focusing on stocks related to the genomic revolution. The "ARK Genomic Revolution Fund Guru Tracker" is based on ARKG's daily disclosure reports, helping investors track its investment strategy.

    • ARKG Investment TrackerARKG Investment Tracker
      ·06-25 07:13
      ARKG Investment Tracker position change: Increased position in Alamar Biosciences by 2,134 shares, the number of shares held increased 0.38% compared to the previous period and now represents 0.94% of the total position.
      71Comment
      Report
    • ARKG Investment TrackerARKG Investment Tracker
      ·06-25 07:13
      ARKG Investment Tracker position change: Decreased position in Twist Bioscience Corp by 20,284 shares, the number of shares held decreased 1.31% compared to the previous period and now represents 9.4% of the total position.
      147Comment
      Report
    • ARKG Investment TrackerARKG Investment Tracker
      ·06-24 07:13
      ARKG Investment Tracker position change: Increased position in Prime Medicine, Inc. by 17,868 shares, the number of shares held increased 0.39% compared to the previous period and now represents 1.06% of the total position.
      2Comment
      Report
    • ARKG Investment TrackerARKG Investment Tracker
      ·06-24 07:13
      ARKG Investment Tracker position change: Increased position in Ionis Pharmaceuticals by 1,044 shares, the number of shares held increased 0.39% compared to the previous period and now represents 1.42% of the total position.
      28Comment
      Report
    • ARKG Investment TrackerARKG Investment Tracker
      ·06-24 07:13
      ARKG Investment Tracker position change: Increased position in COMPASS Pathways plc by 12,027 shares, the number of shares held increased 0.39% compared to the previous period and now represents 2.76% of the total position.
      9Comment
      Report
    • ARKG Investment TrackerARKG Investment Tracker
      ·06-24 07:13
      ARKG Investment Tracker position change: Increased position in Eli Lilly by 6,132 shares, the number of shares held increased 25.69% compared to the previous period and now represents 2.35% of the total position.
      4Comment
      Report
    • ARKG Investment TrackerARKG Investment Tracker
      ·06-24 07:13
      ARKG Investment Tracker position change: Increased position in GeneDx Holdings by 1,659 shares, the number of shares held increased 0.39% compared to the previous period and now represents 1.8% of the total position.
      69Comment
      Report
    • ARKG Investment TrackerARKG Investment Tracker
      ·06-24 07:13
      ARKG Investment Tracker position change: Decreased position in Intellia Therapeutics by 14,612 shares, the number of shares held decreased 0.52% compared to the previous period and now represents 3.12% of the total position.
      111Comment
      Report
    • ARKG Investment TrackerARKG Investment Tracker
      ·06-24 07:13
      ARKG Investment Tracker position change: Increased position in Alamar Biosciences by 5,211 shares, the number of shares held increased 0.93% compared to the previous period and now represents 0.89% of the total position.
      32Comment
      Report
    • ARKG Investment TrackerARKG Investment Tracker
      ·06-24 07:13
      ARKG Investment Tracker position change: Increased position in BioNTech SE by 459 shares, the number of shares held increased 0.39% compared to the previous period and now represents 0.77% of the total position.
      69Comment
      Report
       
       
       
       

      Most Discussed